Simvastatin enhances oxidized-low density lipoprotein-induced macrophage autophagy and attenuates lipid aggregation

Molecular Medicine Reports

Volumn 11, Issue 2, 2015, Pages 1093-1098

  Huang, Baojun ^a   Jin, Mengxing ^a   Yan, Hai ^a   Cheng, Yanwei ^a   Huang, Dake ^a   Ying, Songcheng ^a   Zhang, Linjie ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Cholesterol; Macrophage; Oxidized low density lipoprotein; Simvastatin

Indexed keywords

CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN; MAP1LC3 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SIMVASTATIN;

ANIMAL; AUTOPHAGY; CELL LINE; CYTOLOGY; DRUG EFFECTS; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AUTOPHAGY; CELL LINE; CHOLESTEROL; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICROTUBULE-ASSOCIATED PROTEINS; SIMVASTATIN;

EID: 84916233265     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2790     Document Type: Article

References (22)

1. Legein B, Temmerman L, Biessen EA and Lutgens E: Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci 70: 3847-3869, 2013.
2. Cybulsky MI, Won D and Haidari M: Leukocyte recruitment to atherosclerotic lesions. Can J Cardiol 20: 24B-28B, 2004.
3. Moore KJ, Sheedy FJ and Fisher EA: Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13: 709-721, 2013.
4. Martinet W and De Meyer GR: Autophagy in atherosclerosis. Curr Atheroscler Rep 10: 216-223, 2008.
5. Martinet W and De Meyer GR: Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res 104: 304-317, 2009.
6. Schrijvers DM, De Meyer GR and Martinet W: Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol 31: 2787-2791, 2011.
7. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J and Tabas I: Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 15: 545-553, 2012.
8. Zhang YL, Cao YJ, Zhang X, Liu HH, Tong T, Xiao GD, Yang YP and Liu CF: The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells. Biochem Biophys Res Commun 394: 377-382, 2010.
9. Muller C, Salvayre R, Ngre-Salvayre A and Vindis C: HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs. Cell Death Differ 18: 817-828, 2011.
10. Almuti K, Rimawi R, Spevack D and Ostfeld RJ: Effects of statins beyond lipid lowering: potential for clinical benefits. Int J Cardiol 109: 7-15, 2006.
11. Bu DX, Griffin G and Lichtman AH: Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 22: 165-170, 2011.
12. Wierzbicki AS, Poston R and Ferro A: The lipid and non-lipid effects of statins. Pharmacol Ther 99: 95-112, 2003.
13. Marzilli M: Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering. Am J Cardiovasc Drugs 10 (Suppl 1): 3-9, 2010.
14. Wei YM, Li X, Xu M, Abais JM, Chen Y, Riebling CR, Boini KM, Li PL and Zhang Y: Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 31: 925-937, 2013.
15. Zhang M, Huang BJ, Hu MC, Chen YW, Song W, Huang DK, Li Q and Hu CS: Lipopolysaccharide induces formation of autophagy-related LC3B-GFP fluorescent aggregates in the RAW264.7 macropahge cells. J Anhui Medical Uni 47: 357-361, 2012 (In Chinese).
16. Nowicki M, Zabirnyk O, Duerrschmidt N, Borlak J and Spanel-Borowski K: No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy. Eur J Cell Biol 86: 605-616, 2007.
17. Lai EH, Hong CY, Kok SH, Hou KL, Chao LH, Lin LD, Chen MH, Wu PH and Lin SK: Simvastatin alleviates the progression of periapical lesions by modulating autophagy and apoptosis in osteoblasts. J Endod 38: 757-763, 2012.
18. Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP and Cal LA: The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm 2013: 714653, 2013.
19. Mitra S, Goyal T and Mehta JL: Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther 25: 419-429, 2011.
20. Ding Z, Wang X, Khaidakov M, Liu S, Dai Y and Mehta JL: Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells. Biochem Biophys Res Commun 426: 106-111, 2012.
21. Ouimet M and Marcel YL: Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 32: 575-581, 2012.
22. Martinet W, De Meyer I, Verheye S, Schrijvers DM, Timmermans JP and De Meyer GR: Drug-induced macrophage autophagy in atherosclerosis: for better or worse? Basic Res Cardiol 108: 321, 2013.